素酸在预防阴道分娩产后流血:一项双盲随机对照试验
Pratibha Arya1, Garima Yadav1, Pratibha Singh1
1Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Basni, Jodhpur, India.
American journal of obstetrics & gynecology MFM
|August 3, 2024
概括
预防性三胺酸 (TXA) 在积极管理下使用时,不会减少产后血流或阴道分娩后出血. 这项研究没有发现TXA在预防产后出血 (PPH) 的额外益处.
科学领域:
- 产科和妇科 产科和妇科
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 产后出血 (PPH) 是全球主要的孕产妇死亡原因之一.
- 胺酸 (TXA) 用于治疗PPH,但其在阴道分娩后的预防作用尚未研究.
研究的目的:
- 为了评估预防性三胺酸 (TXA) 在减少产后血流和PPH发病率方面的疗效.
- 评估TXA在阴道分娩期间与分娩第三阶段的积极管理相结合时的益处.
主要方法:
- 一项随机对照试验,涉及650名经过阴道分娩的妇女.
- 参与者通过静脉注射接受了1g的tranexamic酸或安慰剂.
- 使用校准收集袋测量产后血流量.
主要成果:
- 在TXA和安慰剂组 (378.5毫升与383.0毫升) 之间,平均血液损失没有显著差异.
- PPH发生率相似:TXA组的15.9%,安慰剂组的15.3%.
- 血红蛋白降低或诸如血栓栓塞等不良事件没有显著差异.
结论:
- 预防性三胺酸 (TXA) 在减少产后血流或PPH发生率方面没有额外的好处.
- 目前的证据表明,当与积极管理相结合时,TXA对通过阴道分娩的PPH预防无益.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Local Anesthetics: Clinical Application as Epidural Anesthesia
427
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
427
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
381
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
381
Vascular Spasm
1.3K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.3K
Extrinsic and Intrinsic Pathways of Hemostasis
6.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.7K


